In this episode, James discusses the use of computational biology, AI, and machine learning in biotech to identify disease-causing genes and develop potential treatments. His guest, Jack O'Meara, CEO of Ochre Bio, shares their ambitious approach of using human livers models for testing drug candidates, aiming to replace animal testing and improve the qualification of drugs for human clinical trials. They explore the potential impact of this innovation, including the FDA's potential ban on animal testing, and highlight the economic benefits and advancements it can bring to the pharmaceutical industry.

Apply to be a guest: www.thehealthtechpodcast.com

Subscribe to Healthtech Pigeon 🐦:
www.healthtechpigeon.com

Get in touch with James: www.jamessomauroo.com

Learn more about SomX for your healthtech company at somx.health